The NLRP3 inflammasome as a bridge between myocardial infarction and depression: mechanisms, bidirectional link, and therapeutic potential
- 1Tianhua College, Shanghai Normal University
- 2Department of Rehabilitation Medicine, The Second Affiliated Hospital of Anhui Medical University
Abstract
Myocardial infarction (MI) and depression frequently co-occur and form a bidirectional relationship that worsens patient outcomes, with inflammation serving as a core mechanism linking these two disorders. The NLRP3 inflammasome, a key component of the innate immune system, plays a pivotal role in sterile inflammatory responses. This review systematically summarizes the structural characteristics, activation mechanisms, and pathophysiological functions of the NLRP3 inflammasome, with a particular focus on its involvement in the pathogenesis of MI and depression and the bidirectional relationship between the two diseases. We comprehensively elaborate on the role of the NLRP3 inflammasome as a molecular bridge between MI and depression, exploring mechanisms including oxidative stress and mitochondrial dysfunction, ATP-P2X7 signaling and calcium pathways, peripheral and central inflammation, sympathetic and vagus nerve pathways, the gut microbiota-gut-brain axis, neurotransmitter and neurotrophic metabolic dysregulation, VEGF-mediated vascular permeability, metabolic disturbances, and neuroendocrine dysfunction. We also discuss the clinical implications of NLRP3-related molecules as biomarkers for predicting treatment responses and analyze the role of the NLRP3 inflammasome in treatment sensitivity and resistance within heart-brain comorbidity. Finally, we summarize current therapeutic strategies targeting the NLRP3 inflammasome and propose future research directions. We propose that NLRP3 inflammasome activation is a common upstream driver of both cardiac remodeling and depressive neuroinflammation, and that its persistence explains why standard therapies often fail in comorbid patients. Targeting NLRP3 may therefore break the self-sustaining inflammatory loop that perpetuates the comorbidity. Targeting the NLRP3 inflammasome may represent a novel strategy for breaking the vicious cycle between MI and depression, offering potential benefits for both cardiovascular and mental health. Importantly, direct evidence for NLRP3 as a causal mediator in comorbidity-specific systems remains limited; we therefore present this as an integrative framework that synthesizes parallel pathways and identifies critical knowledge gaps.
Related
- Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery
- The heart-liver axis controls platelet turnover by hepatic STAT3 phosphorylation and TPO regulation after acute myocardial infarction
- Efficacy and safety of bone marrow mononuclear cell therapy for myocardial infarction: a dose–response meta-analysis
- Stress hyperglycemia impairs FOXK2-dependent macrophage cardiac repair after myocardial infarction
- Myocardial lipid remodeling in patients with myocardial infarction undergoing cardiac surgery
BibTeX
@article{zhou2026nlrp3,
title = {{The NLRP3 inflammasome as a bridge between myocardial infarction and depression: mechanisms, bidirectional link, and therapeutic potential}},
author = {Pingping Zhou and Yuan Ma and Chen Hou and Cuicui Chen and Shuang Deng},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = oct,
doi = {10.3389/fcvm.2026.1924945},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1924945/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The NLRP3 inflammasome as a bridge between myocardial infarction and depression: mechanisms, bidirectional link, and therapeutic potential
AU - Pingping Zhou
AU - Yuan Ma
AU - Chen Hou
AU - Cuicui Chen
AU - Shuang Deng
PY - 2026
DA - 2026/10/08
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1924945
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1924945/full
AB - Myocardial infarction (MI) and depression frequently co-occur and form a bidirectional relationship that worsens patient outcomes, with inflammation serving as a core mechanism linking these two disorders. The NLRP3 inflammasome, a key component of the innate immune system, plays a pivotal role in sterile inflammatory responses. This review systematically summarizes the structural characteristics, activation mechanisms, and pathophysiological functions of the NLRP3 inflammasome, with a particular focus on its involvement in the pathogenesis of MI and depression and the bidirectional relationship between the two diseases. We comprehensively elaborate on the role of the NLRP3 inflammasome as a molecular bridge between MI and depression, exploring mechanisms including oxidative stress and mitochondrial dysfunction, ATP-P2X7 signaling and calcium pathways, peripheral and central inflammation, sympathetic and vagus nerve pathways, the gut microbiota-gut-brain axis, neurotransmitter and neurotrophic metabolic dysregulation, VEGF-mediated vascular permeability, metabolic disturbances, and neuroendocrine dysfunction. We also discuss the clinical implications of NLRP3-related molecules as biomarkers for predicting treatment responses and analyze the role of the NLRP3 inflammasome in treatment sensitivity and resistance within heart-brain comorbidity. Finally, we summarize current therapeutic strategies targeting the NLRP3 inflammasome and propose future research directions. We propose that NLRP3 inflammasome activation is a common upstream driver of both cardiac remodeling and depressive neuroinflammation, and that its persistence explains why standard therapies often fail in comorbid patients. Targeting NLRP3 may therefore break the self-sustaining inflammatory loop that perpetuates the comorbidity. Targeting the NLRP3 inflammasome may represent a novel strategy for breaking the vicious cycle between MI and depression, offering potential benefits for both cardiovascular and mental health. Importantly, direct evidence for NLRP3 as a causal mediator in comorbidity-specific systems remains limited; we therefore present this as an integrative framework that synthesizes parallel pathways and identifies critical knowledge gaps.
SN - 2297-055X
ER -